diethylnitrosamine has been researched along with Hyperlipemia in 2 studies
Diethylnitrosamine: A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties.
N-nitrosodiethylamine : A nitrosamine that is N-ethylethanamine substituted by a nitroso group at the N-atom.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Interestingly, HFD, which induced hyperlipidemia and hepatic steatosis, attenuated DEN-related malnutrition and fibrosis progression in HFD + DEN group during 10-14 weeks." | 5.40 | High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma. ( Ding, WJ; Duan, XY; Fan, JG; Pan, Q; Qiao, L; Yan, SY, 2014) |
| "Interestingly, HFD, which induced hyperlipidemia and hepatic steatosis, attenuated DEN-related malnutrition and fibrosis progression in HFD + DEN group during 10-14 weeks." | 1.40 | High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma. ( Ding, WJ; Duan, XY; Fan, JG; Pan, Q; Qiao, L; Yan, SY, 2014) |
| "NDEA-induced rats showed severe hyperlipidemia along with upregulated expression of COX-2 as revealed by western blotting and immunohistochemistry." | 1.35 | Silymarin downregulates COX-2 expression and attenuates hyperlipidemia during NDEA-induced rat hepatocellular carcinoma. ( Anandakumar, P; Augustine, TA; Devaki, T; Elinos-Báez, CM; Jagan, S; Kamaraj, S; Ramakrishnan, G, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, XY | 1 |
| Pan, Q | 1 |
| Yan, SY | 1 |
| Ding, WJ | 1 |
| Fan, JG | 1 |
| Qiao, L | 1 |
| Ramakrishnan, G | 1 |
| Elinos-Báez, CM | 1 |
| Jagan, S | 1 |
| Augustine, TA | 1 |
| Kamaraj, S | 1 |
| Anandakumar, P | 1 |
| Devaki, T | 1 |
2 other studies available for diethylnitrosamine and Hyperlipemia
| Article | Year |
|---|---|
High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Topics: Animals; Apoptosis; Carcinogens; Carcinoma, Hepatocellular; Cell Proliferation; Diet, High-Fat; Diet | 2014 |
Silymarin downregulates COX-2 expression and attenuates hyperlipidemia during NDEA-induced rat hepatocellular carcinoma.
Topics: Animals; Arachidonic Acid; Carcinoma, Hepatocellular; Cholesterol, HDL; Cyclooxygenase 2; Diethylnit | 2008 |